PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells
Background: Modification of human airway smooth muscle (ASM) function by proinflammatory cytokines has been regarded as a potential mechanism underlying bronchial hyperresponsiveness in asthma. Human ASM cells express intercellular adhesion molecule (ICAM)-1 in response to cytokines. Synthetic ligan...
Main Authors: | Chien-Da Huang, Te-Chih Hsiung, Shu-Chuan Ho, Kang-Yun Lee, Yao-Fei Chan, Li-Wei Kuo, Shu-Min Lin, Chun-Hua Wang, Horng-Chyuan Lin, Han-Pin Kuo |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-08-01
|
Series: | Biomedical Journal |
Subjects: | |
Online Access: | http://www.biomedj.org/article.asp?issn=2319-4170;year=2014;volume=37;issue=4;spage=191;epage=198;aulast=Huang |
Similar Items
-
Ciglitazone—a human PPARγ agonist—disrupts dorsoventral patterning in zebrafish
by: Vanessa Cheng, et al.
Published: (2019-11-01) -
Airway smooth muscle function in asthma
by: Dora (Jun Ping) Xiong, et al.
Published: (2022-10-01) -
PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01) -
Th1 cytokines synergize to change gene expression and promote corticosteroid insensitivity in pediatric airway smooth muscle
by: Devine Jackson, et al.
Published: (2022-05-01) -
Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis
by: Khan Mohammad Afzal
Published: (2013-02-01)